Variable | Category | Frequency | Percentage |
---|---|---|---|
WHO clinical stage | Stage-I | 73 | 16.7 |
Stage-II | 167 | 38.22 | |
Stage-III | 129 | 29.52 | |
Stage-IV | 68 | 15.56 | |
Sex | Male | 284 | 64.99 |
Female | 153 | 35.01 | |
Co-infection HIV/TB | No | 292 | 66.82 |
Yes | 147 | 33.64 | |
Education level | Elementary and below | 143 | 32.72 |
Secondary and above | 294 | 67.28 | |
Residence | Urban | 286 | 65.45 |
Rural | 151 | 34.55 | |
Functional status | Working | 291 | 66.59 |
Ambulatory | 98 | 22.43 | |
Bedridden | 48 | 10.98 | |
Opportunistic infection | No | 160 | 36.61 |
Yes | 277 | 63.39 | |
Adverse drug events | No | 269 | 61.56 |
Yes | 168 | 38.44 | |
Age category | < 2 years | 43 | 9.84 |
2–5 years | 374 | 85.58 | |
6–14 years | 20 | 4.577 | |
Adherence level | Good | 204 | 46.68 |
Fair | 135 | 30.89 | |
Poor | 98 | 22.43 |